Bait Competitors

Stocks . Israel . 
Stock . Bait Bakfar
BKFR Stock   1,409  7.00  0.50%   
Bait Bakfar competes with Sofwave Medical, Brainsway, Novolog Pharm, Kamada, and Ilex Medical; as well as few others. Analyzing Bait Bakfar competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Bait Bakfar to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.

Bait Bakfar vs Oramed Pharmaceuticals Correlation

Good diversification

The correlation between Bait Bakfar and ORMP is -0.16 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Bait Bakfar and ORMP in the same portfolio, assuming nothing else is changed.

Moving together with Bait Stock

  0.62NICE NicePairCorr

Moving against Bait Stock

  0.61CLIS Clal Insurance EnterPairCorr
  0.59DSCT Israel Discount BankPairCorr
  0.49RMLI Rami LeviPairCorr
  0.46MZTF Mizrahi Tefahot Earnings Call This WeekPairCorr
  0.46ENLT Enlight Renewable EnergyPairCorr

Bait Bakfar Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Bait Bakfar and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Bait and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Bait Bakfar does not affect the price movement of the other competitor.

High positive correlations

KMDA
+ 0.89
SOFW
KMDA
+ 0.88
BWAY
BWAY
+ 0.86
SOFW
ORMP
+ 0.81
BWAY
ORMP
+ 0.69
KMDA
ORMP
+ 0.67
SOFW
  

High negative correlations

LCTX
- 0.65
BWAY
ORMP
- 0.6
LCTX
LCTX
- 0.56
KMDA
LCTX
- 0.56
SOFW
GOHO
- 0.47
MRHL
GOHO
- 0.44
BWAY

Risk-Adjusted Indicators

There is a big difference between Bait Stock performing well and Bait Bakfar Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bait Bakfar's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
SOFW  2.13  0.15  0.07  0.16  2.18 
(2.22)
 4.02 
(4.07)
 16.52 
BWAY  2.40  0.63  0.21  0.94  2.33 
(2.55)
 6.75 
(4.11)
 14.59 
NVLG  1.26 (0.08) 0.00  4.90  0.00 
 0.00 
 2.51 
(3.48)
 10.72 
KMDA  1.78  0.31  0.11 (1.16) 1.90 
(1.98)
 4.79 
(3.73)
 10.78 
ILX  1.55 (0.21) 0.00  3.19  0.00 
 0.00 
 3.01 
(3.98)
 11.05 
LCTX  2.79 (0.08) 0.00  0.20  0.00 
 0.00 
 6.09 
(6.26)
 20.31 
MRHL  7.16  1.64  0.19  15.61  6.87 
(8.80)
 17.76 
(10.06)
 78.79 
GOHO  2.31 (0.03)(0.02) 0.00  3.07 
(2.47)
 5.19 
(5.14)
 17.41 
CGEN  2.62  0.03 (0.01)(0.05) 3.07 
(2.90)
 6.30 
(4.81)
 17.51 
ORMP  3.00  0.50  0.16  1.71  2.58 
(3.80)
 8.17 
(4.38)
 15.51 

Bait Bakfar Competitive Analysis

The better you understand Bait Bakfar competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Bait Bakfar's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Bait Bakfar's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
BKFR SOFW BWAY NVLG KMDA ILX LCTX MRHL GOHO CGEN
 0.50 
 1,409 
Bait
 1.91 
 3,486 
Sofwave
 2.25 
 3,954 
Brainsway
 1.61 
 119.70 
Novolog
 0.56 
 2,685 
Kamada
 0.77 
 5,746 
Ilex
 2.00 
 530.30 
Lineage
 2.46 
 195.70 
Merchavia
 6.23 
 1,024 
Golden
 0.52 
 524.70 
Compugen
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Market Performance
(90 Days Performance)
Weakest
Good
Solid
Weakest
Good
Weakest
Weakest
Fair
Weakest
Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Unknown
Small
Small
Low
Low
Low
Small
Low
Small
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Fairly Valued
Under Valued
Over Valued
Under Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Hold
Strong Buy
Strong Sell
Hold
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Current Ratio
N/A
N/A
9.26
0.96
6.86
1.75
10.58
12.04
0.41
9.6
Net Asset
N/A
N/A
75.73 M
2.29 B
318.67 M
875.07 M
N/A
N/A
N/A
132.16 M
Profit Margin
N/A
-0.61
-0.37
0.0307
-0.089
0.12
N/A
0.5
1.0
N/A
EBITDA
N/A
(15.14 M)
(3.31 M)
115.92 M
5 M
307.85 M
(24.77 M)
9.49 M
22.72 M
(35.07 M)
Operating Margin
N/A
-0.62
-0.29
0.053
-0.0086
0.18
N/A
0.75
0.35
N/A
Current Valuation
N/A
174.37 M
(85.93 M)
1.45 B
636.38 M
901.49 M
1.3 B
44.44 M
412.23 M
12.53 M
Price To Book
N/A
2.19
0.65
3.24
1.13
1.83
N/A
N/A
N/A
1.13
Retained Earnings
N/A
N/A
N/A
N/A
(107 M)
N/A
N/A
(12 M)
173 M
N/A
Current Asset
N/A
N/A
N/A
N/A
85 M
N/A
N/A
10 M
51 M
91 M
Five Year Return
N/A
N/A
N/A
N/A
N/A
2.47
N/A
N/A
2.99
N/A
Beta
N/A
N/A
0.2
0.2
0.25
-0.11
1.84
0.6
0.25
2.58
Number Of Employees
N/A
92
118
900
355
254
49
1
147
73
Shares Outstanding
N/A
34.15 M
33.08 M
508.7 M
44.8 M
11.19 M
N/A
82.13 M
15.57 M
86.62 M
Cash Flow From Operations
N/A
N/A
884 K
83.39 M
(8.82 M)
270.68 M
(23.33 M)
(2.61 M)
(5.66 M)
(22.75 M)
Annual Yield
N/A
N/A
N/A
0.0302
N/A
0.0589
N/A
N/A
0.0362
N/A
Total Debt
N/A
N/A
672 K
916 K
17.41 M
1.28 M
2.9 M
N/A
256.34 M
2.85 M
Return On Equity
N/A
-0.35
-0.2
0.11
-0.058
0.19
-10.82
0.14
0.21
-0.44
Z Score
N/A
N/A
N/A
N/A
22.8
N/A
N/A
N/A
N/A
52.8
Return On Asset
N/A
-0.18
-0.0751
0.0174
-0.0023
0.12
-13.19
0.13
0.0178
-0.23
Book Value Per Share
N/A
1.12
1.46
0.86
3.93
51.14
0.63
0.5
20.22
0.92
Current Liabilities
N/A
N/A
N/A
N/A
27 M
N/A
N/A
8 M
174 M
6.85 M
Total Asset
N/A
N/A
75.73 M
2.29 B
318.67 M
875.07 M
N/A
25 M
561 M
132.16 M
Debt To Equity
N/A
N/A
0.034
0.6
0.025
38.0
0.023
18.7
0.94
0.027
Target Price
N/A
N/A
14.0
2.1
11.0
N/A
N/A
N/A
N/A
N/A
Last Dividend Paid
N/A
N/A
N/A
0.063
N/A
5.32
N/A
N/A
0.39
N/A
Shares Owned By Institutions
N/A
22.84
1.11
40.71
32.04
10.16
43.81
5.48
28.9
27.56
Market Capitalization
N/A
392.36 M
116.06 M
1.09 B
667.53 M
1.01 B
N/A
24.47 M
155.68 M
251.35 M
Price To Sales
N/A
10.41
3.76
0.99
5.37
1.16
N/A
2.38
2.79
46.89
Net Income
N/A
N/A
(6.46 M)
42.32 M
(2.23 M)
197.48 M
(11.93 M)
5.85 M
11.74 M
(34.2 M)
Earnings Per Share
N/A
-0.29
-0.22
0.08
-0.15
9.75
-0.14
0.07
3.35
-0.4
Shares Owned By Insiders
N/A
53.24
19.83
42.45
18.5
62.44
4.5
58.68
66.15
5.5
Revenue
N/A
25.33 M
29.66 M
1.26 B
103.64 M
1.06 B
1.83 M
12.6 M
60.7 M
6 M
Working Capital
N/A
N/A
N/A
N/A
58 M
N/A
N/A
2 M
(123 M)
84.14 M
Cash And Equivalents
N/A
N/A
55.87 M
107.97 M
104.55 M
118.65 M
68.75 M
4.77 M
71.39 M
110.41 M
Cash Per Share
N/A
N/A
1.73
0.31
2.23
11.8
0.41
0.08
4.59
1.32
Gross Profit
N/A
16.21 M
24.35 M
154.67 M
30.33 M
379.38 M
1.44 M
10.61 M
28.74 M
5.32 M
Day Typical Price
1403.67
3495.33
3990.67
118.47
2681.33
5661.0
530.8
190.33
1042.0
525.0
Accumulation Distribution
99.59
1098.2
10923.14
9856.84
2633.38
605.9
23.85
3020.42
11.42
368.45
Market Facilitation Index
0.0113
0.003
9.0E-4
0.0
0.0013
0.0276
0.0029
4.0E-4
0.24
5.0E-4
Daily Balance Of Power
0.175
(0.63)
(0.45)
0.5135
(0.16)
0.1415
1.704918
0.2919
(1.26)
0.2621
Period Momentum Indicator
7.0
(68.00)
(91.00)
1.9
(15.00)
44.0
10.4
4.7
(68.00)
2.7
Rate Of Daily Change
1.0
0.98
0.98
1.02
0.99
1.01
1.02
1.02
0.94
1.01
Day Median Price
1401.0
3500.0
4009.0
117.85
2679.5
5618.5
531.05
187.65
1051.0
525.15
Price Action Indicator
11.5
(48.00)
(100.50)
2.8
(2.00)
149.5
4.45
10.4
(61.00)
0.9
Relative Strength Index
36.01
64.13
49.61
35.55
57.41
37.0
36.83
37.17
51.72
43.89
Coefficient Of Variation
(979.48)
1230.41
472.1
(2,664)
783.15
(1,058)
(4,218)
689.3
25478.25
14674.63
Mean Deviation
0.8458
2.13
2.4
1.26
1.78
1.55
2.79
7.16
2.31
2.62
Jensen Alpha
(0.13)
0.1519
0.6331
(0.08)
0.308
(0.21)
(0.08)
1.64
(0.03)
0.0293
Total Risk Alpha
(0.22)
0.0234
0.4466
(0.21)
0.1278
(0.36)
(0.39)
0.8496
(0.22)
(0.23)
Sortino Ratio
N/A
0.0703
0.212
N/A
0.1127
N/A
N/A
0.1934
(0.02)
(0.01)
Downside Variance
N/A
6.19
8.5
N/A
4.57
N/A
N/A
68.02
11.49
9.98
Standard Deviation
1.22
2.93
3.22
1.84
2.38
2.15
4.01
11.43
3.17
3.47
Kurtosis
2.32
2.93
0.743
2.65
0.1544
0.8269
3.0
7.17
0.8286
0.8646
Potential Upside
2.48
4.02
6.75
2.51
4.79
3.01
6.09
17.76
5.19
6.3
Treynor Ratio
2.39
0.1597
0.9379
4.9
(1.16)
3.19
0.2015
15.61
0.004
(0.05)
Maximum Drawdown
7.63
16.52
14.59
10.72
10.78
11.05
20.31
78.79
17.41
17.51
Variance
1.5
8.61
10.35
3.37
5.68
4.62
16.1
130.73
10.06
12.02
Market Risk Adjusted Performance
2.4
0.1697
0.9479
4.91
(1.15)
3.2
0.2115
15.62
0.014
(0.04)
Risk Adjusted Performance
(0.07)
0.0697
0.1699
(0.02)
0.1046
(0.07)
(0.01)
0.1205
0.0106
0.013
Skewness
0.9105
1.17
0.627
0.6806
0.3007
(0.48)
0.529
1.86
0.1748
0.504
Semi Deviation
N/A
2.18
2.33
N/A
1.9
N/A
N/A
6.87
3.07
3.07
Information Ratio
(0.15)
0.0596
0.1921
(0.07)
0.101
(0.12)
(0.04)
0.1395
(0.02)
(0.01)
Value At Risk
(1.41)
(4.07)
(4.11)
(3.48)
(3.73)
(3.98)
(6.26)
(10.06)
(5.14)
(4.81)
Expected Short fall
N/A
(2.22)
(2.55)
N/A
(1.98)
N/A
N/A
(8.80)
(2.47)
(2.90)
Downside Deviation
N/A
2.49
2.91
N/A
2.14
N/A
N/A
8.25
3.39
3.16
Semi Variance
N/A
4.74
5.45
N/A
3.59
N/A
N/A
47.16
9.45
9.41

Bait Bakfar Competition Performance Charts

Five steps to successful analysis of Bait Bakfar Competition

Bait Bakfar's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Bait Bakfar in relation to its competition. Bait Bakfar's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Bait Bakfar in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Bait Bakfar's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Bait Bakfar, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Bait Bakfar position

In addition to having Bait Bakfar in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Top Crypto Assets Thematic Idea Now

Top Crypto Assets
Top Crypto Assets Theme
An experimental p2p digital currency that is accepted by many vendors in null. The Top Crypto Assets theme has 0 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Top Crypto Assets Theme or any other thematic opportunities.
View All  Next Launch
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY